Literature DB >> 28293040

Gene editing using CRISPR-Cas9 for the treatment of lung cancer.

Andres Castillo1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 28293040      PMCID： PMC5335857     

Source DB:  PubMed          Journal:  Colomb Med (Cali)        ISSN： 0120-8322


× No keyword cloud information.
  11 in total

1.  Biological significance of a family of regularly spaced repeats in the genomes of Archaea, Bacteria and mitochondria.

Authors:  F J Mojica; C Díez-Villaseñor; E Soria; G Juez
Journal:  Mol Microbiol       Date:  2000-04       Impact factor: 3.501

2.  Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements.

Authors:  Francisco J M Mojica; César Díez-Villaseñor; Jesús García-Martínez; Elena Soria
Journal:  J Mol Evol       Date:  2005-02       Impact factor: 2.395

Review 3.  CRISPR/Cas, the immune system of bacteria and archaea.

Authors:  Philippe Horvath; Rodolphe Barrangou
Journal:  Science       Date:  2010-01-08       Impact factor: 47.728

4.  CRISPR-Cas9: A European position on genome editing.

Authors:  François Hirsch; Yves Lévy; Hervé Chneiweiss
Journal:  Nature       Date:  2017-01-04       Impact factor: 49.962

5.  CRISPR gene-editing tested in a person for the first time.

Authors:  David Cyranoski
Journal:  Nature       Date:  2016-11-24       Impact factor: 49.962

6.  Chinese scientists to pioneer first human CRISPR trial.

Authors:  David Cyranoski
Journal:  Nature       Date:  2016-07-28       Impact factor: 49.962

7.  Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product.

Authors:  Y Ishino; H Shinagawa; K Makino; M Amemura; A Nakata
Journal:  J Bacteriol       Date:  1987-12       Impact factor: 3.490

Review 8.  CRISPR interference: RNA-directed adaptive immunity in bacteria and archaea.

Authors:  Luciano A Marraffini; Erik J Sontheimer
Journal:  Nat Rev Genet       Date:  2010-03       Impact factor: 53.242

9.  Long stretches of short tandem repeats are present in the largest replicons of the Archaea Haloferax mediterranei and Haloferax volcanii and could be involved in replicon partitioning.

Authors:  F J Mojica; C Ferrer; G Juez; F Rodríguez-Valera
Journal:  Mol Microbiol       Date:  1995-07       Impact factor: 3.501

10.  Inactivation of Cancer Mutations Utilizing CRISPR/Cas9.

Authors:  Christina Gebler; Tim Lohoff; Maciej Paszkowski-Rogacz; Jovan Mircetic; Debojyoti Chakraborty; Aylin Camgoz; Martin V Hamann; Mirko Theis; Christian Thiede; Frank Buchholz
Journal:  J Natl Cancer Inst       Date:  2016-08-30       Impact factor: 13.506
View more
  3 in total

Review 1.  Non-viral delivery systems for CRISPR/Cas9-based genome editing: Challenges and opportunities.

Authors:  Ling Li; Shuo Hu; Xiaoyuan Chen
Journal:  Biomaterials       Date:  2018-04-18       Impact factor: 12.479

Review 2.  Current Applications and Future Perspectives of CRISPR-Cas9 for the Treatment of Lung Cancer.

Authors:  Markeshaw Tiruneh G/Medhin; Endeshaw Chekol Abebe; Tekeba Sisay; Nega Berhane; Tesfahun Bekele; Tadesse Asmamaw Dejenie
Journal:  Biologics       Date:  2021-05-31

Review 3.  In Vivo Genome Editing as a Therapeutic Approach.

Authors:  Beatrice Xuan Ho; Sharon Jia Hui Loh; Woon Khiong Chan; Boon Seng Soh
Journal:  Int J Mol Sci       Date:  2018-09-12       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.